http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019016511-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_990f841fc6d500d787e149df505e342d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51f8c4298ee7818439743df297034684
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133
filingDate 2018-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4026a4c89d7c0363ac47588804e79e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99ef395ce80725e3e517662ed0b7985e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b833c1e9bf10ed9446920954d360d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a66fe7c0b2396badaf8b052b7281ec6
publicationDate 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019016511-A3
titleOfInvention NOVEL CRYSTALLINE POLYMORPHIC FORMS OF VILANTEROL TRIFENATATE AND PREPARATION METHODS THEREOF
abstract The present invention relates to novel crystalline forms of vilanterol trifenatate, processes for their preparation, and their use in a pharmaceutical composition for the treatment of respiratory diseases, particularly for the treatment of asthma and chronic obstructive pulmonary disease. . In particular, the present invention relates to a crystalline form of vilanterol trifenatate characterized in that the form has an XRPD motif, as defined in the invention, which has characteristic diffraction angles (2-theta or 2Θ (°)) falling within or at each end of one or more of the following ranges: (a) 3 to 5 °, such as 3.8 to 4.4 °; and / or (b) 7 to 9.9 °, such as 7 to 8.5 °; and / or (c) 12 to 13.3 °, such as 12 to 13.3 °; and / or (d) 16.4 to 17.3 °, such as 16.4 to 17.3 °; and / or (e) 26.8 to 28.3 °, such as 26.8 to 28.3 °.
priorityDate 2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017001907-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450299347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44482554

Total number of triples: 27.